 MIAMI, June 17, 2021 GLOBE NEWSWIRE -- OPKO Health, Inc. NASDAQ: OPK announces that its subsidiary, EirGen Pharma, Ltd., has entered into a definitive agreement to sell one of its facilities in Waterford, Ireland to Horizon Therapeutics plc Nasdaq: HZNP for 65 million in cash less certain assumed and accrued liabilities relating to transferred employees. The facility houses EirGens sterile-fill-finish business. EirGens research and development employees who were located at the site will transition to a new facility. 